Clinical Trial Update: Bisphosphonate Therapy for Osteogenesis Imperfecta [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating bisphosphonate therapy for osteogenesis imperfecta; the study is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta
• Osteoporosis
• Paget Disease of Bone

Drugs mentioned

• Bisphosphonate therapy (bisphosphonate)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Osteogenesis Imperfecta, Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2016-03-31